Search Within

Alexandra Miller

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (31)
  2. Journal Article (10)
  3. Research Letter (2)
Groups
  1. GSK Faculty (43)
  2. Human Oncology and Pathogenesis Program (43)
  3. Tow Center for Developmental Oncology (TCDO) (38)
  4. Department of Pathology and Laboratory Medicine (36)
  5. Graduate Medical Education (22)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (21)

More Groups

People
  1. Ingo Mellinghoff (37)
  2. Tejus Bale (23)
  3. Maria Arcila (19)
  4. Michael Berger (18)
  5. Elena Pentsova (16)
  6. Marc Ladanyi (16)

More People

Years
  1. 2024 (7)
  2. 2023 (13)
  3. 2022 (8)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Neuro-Oncology (20)
  2. Journal of Neuropathology and Experimental Neurology (4)
  3. Acta Neuropathologica Communications (2)
  4. Clinical Cancer Research (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Oxford University Press (24)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (2)
  4. BioMed Central Ltd. (2)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (43)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Miller, A. M.; Nandakumar, S.; Holle, B. M.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Brannon, A. R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors
    Meeting Abstract

    Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of cerebrospinal fluid circulating tumor DNA (CSF ctDNA) following radiation therapy in patients with leptomeningeal metastasis: Analysis of a randomized phase II trial
    Meeting Abstract

    Goglia, A. G.; Yang, J. T.; Kratochvil, L. B.; Yerramilli, D.; Higginson, D. S.; Miller, A.; Berger, M.; Powell, S. N.; Boire, A.; Wijetunga, N. A.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients
    Meeting Abstract

    Larsen, A. M. G.; Hill, K.; Hickman, R.; Bale, T. A.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Droplet digital PCR enhances detection of hotspot mutations in circulating tumor DNA from cerebrospinal fluid of patients with high-grade glioma
    Meeting Abstract

    Tartaro, M.; Nandakumar, S.; Hertz, C. A.; Holle, B.; Hill, K.; Lapshina, M.; Farina, A.; Arcila, M.; Miller, A.; Mellinghoff, I.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
    Research Letter

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Reiner, A. S.; Cimera, R.; Nandakumar, S.; Price, A.; Vanderbilt, C.; Fahy, T.; Young, R. J.; more...
    Acta Neuropathologica (2023)

    Fulltext@MSK | Save